Cedars-Sinai Medical Center has awarded rights to a preclinical vaccine to prevent recurring brain tumors to StemVax Therapeutics, an emerging biotechnology firm based in Pasadena.
Source: Business

LEAVE A REPLY

Please enter your comment!
Please enter your name here